WuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Facility as Key Equipment Arrives

WuXi Biologics’ Chengdu Microbial Manufacturing Facility Reaches Structural Completion with Key Equipment Installed WuXi Biologics has reached a major construction milestone in its global manufacturing expansion strategy, announcing the structural…

Read MoreWuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Facility as Key Equipment Arrives

Sunnybrook Health Sciences Centre Secures $41 Million Donation to Strengthen Canada’s Leadership in Clinical Trials

Sunnybrook Receives $41 Million Donation to Strengthen Canada’s Global Leadership in Clinical Trials Sunnybrook Health Sciences Centre has announced a transformative $41 million philanthropic investment aimed at reshaping the future…

Read MoreSunnybrook Health Sciences Centre Secures $41 Million Donation to Strengthen Canada’s Leadership in Clinical Trials
Genentech

Genentech Teams Up with Damon Wayans and diaTribe to Launch ‘All Eyes on DME’ Campaign Targeting Diabetes-Related Vision Loss

Genentech Collaborates with Damon Wayans and diaTribe to Raise Awareness of Diabetes-Related Vision Loss Through ‘All Eyes on DME’ Campaign Genentech, a member of the Roche Group, has introduced a…

Read MoreGenentech Teams Up with Damon Wayans and diaTribe to Launch ‘All Eyes on DME’ Campaign Targeting Diabetes-Related Vision Loss

Anaxiom Reports Early First-in-Human Results for Novel Minimally Invasive Obesity Device, Moves Toward U.S. Feasibility Study

Anaxiom Reports Initial First-in-Human Clinical Results for Novel Minimally Invasive Obesity Device, Progresses Toward U.S. Early Feasibility Study Anaxiom Corporation, a clinical-stage innovator focused on developing minimally invasive solutions for…

Read MoreAnaxiom Reports Early First-in-Human Results for Novel Minimally Invasive Obesity Device, Moves Toward U.S. Feasibility Study